TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Repeatability of NTG-Pd/Pa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose response of NTG-Pd/Pa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in VAT/(VAT+SAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in hepatic insulin resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: hematological response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Dynamics of cognitive status
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Preservation of auditory function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effective response rate on the 21st day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effective response rate on the 28th day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in day to day functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in reactive agility time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in reaction time in response to supplement/placebo consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in visual tracking speed in response to supplement/placebo consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in endoscopic Mayo score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Clinical remission derived from patient reported outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean score of behavioral intention
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Hemorrhage clearance evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variation of the proportion of CD4+ subpopulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Variation of the proportion of CD8+ subpopulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Variation of the proportion of TH1 subpopulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Occurrence of post-partum MACCE
Endpoint domain: Mortality/survival
Primary endpoint: Difference in pain level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Assessment of Pain Reaction objectively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of Pain Reaction subjectively
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Platelet reactivity index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean change in blood bicarbonate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Parent satisfaction score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of participants with Adverse events (AEs) and Serious Adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptance rate of intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Post-embolization syndrome incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Gingival Recession Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of grade 4 neutropenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of vaccine side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Immunogenicity measured by anti-Spike antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean cumulative pain index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-operative oedema formation (figure-of-eight tape measurement)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-operative oedema formation (pitting oedema scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-operative oedema formation (bioimpedance analysis)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants adverse events of special interest (AESI)
Endpoint domain: Adverse events/effects
Primary endpoint: Adenoma missed rate
Endpoint domain: Adverse events/effects
Primary endpoint: Baseline levels of ctDNA detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Target Lesion Primary Patency Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Recovery differences in elderly patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of newborns with positive total serum bilirubin blood test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in EDI-R Score from Control Phase to RT Intensive and RT Generalization Phases Combined
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in CP-CTI score from pre-treatment to post-treatment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Adjacent organ thermal injury rate
Endpoint domain: Adverse events/effects
Primary endpoint: segmental ventricular wall motion score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Expression of endometrium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Patients Who Were Composite Weekly Responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in inertial parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Difference in 95th centile of stride velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in 50th centile of stride velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in 95th centile of stride length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in 50th centile of stride length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in creatinine kinase level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of diode and IPL laser in hirsutism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean daily insulin dosage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of acceptability of the intervention to participants
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of recruitment and retention of participants
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Experience of cervical cancer screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Utility of HPV self-collection
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Epworth Sleep Scale (ESS)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Number of monthly heart failure medication adjustment encounters
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage change of seizure frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percent time in range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent time spent in hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent time in severe hyperglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Functional connectivity change between rAI and rSTS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Urinary incontinence severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Functional T cell memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Out Of Pocket (OOP) expenditures
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of inhalers used sub-optimally
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of complications during 12 months follow-up
Endpoint domain: Adverse events/effects
Primary endpoint: Oxygen Saturation (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hepatic Decompensation Event
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of recurrent Coronary Artery Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Retrieval Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microscopic blood contamination assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in knowledge Acquisition Scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: One-leg Standing Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30 Seconds Sit-Stand-on-Chair Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Soft Touch Sense
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total clinical effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in average rates of muscle synthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reliability of PTSD-RI-5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation with Post-Traumatic Stress Disorder National Stressful Events Survey Short Form
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ki-67 expression in tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Concentration of Malondialdehyde (MDA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentration of Hydrogen Peroxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentration of Superoxide dismutase (SOD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentration of Total Antioxidant Capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentration of Glutathione Peroxidase (GPx)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Duration of symptoms of mild COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants clinically recovered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intravaginal and intra-abdominal pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in area under curve (AUC) of individual substrates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in maximum plasma concentration (Cmax) of individual substrates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage reduction of pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caries lesion progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Helical Axes dispersion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance to RSI guidelines
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in RSI complication
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of mRS score recovered to 0~1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Score of Postural Assessment Stroke Scale (PASS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Modified Rankin Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Activity Measure for Post-Acute Care (AMPAC) Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: WHO-5 Well-Being Index
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Tolerability of the TENS device
Endpoint domain: Adverse events/effects
Primary endpoint: Death censored graft loss (DCGL)
Endpoint domain: Mortality/survival
Primary endpoint: Biopsy proven rejection (BPAR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Graft Versus Host Disease (GvHD) and Relapse/rejection-Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients with major adverse cardiovascular events
Endpoint domain: Adverse events/effects
Primary endpoint: Brain activity during walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean duration of menstruation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thickness of the residual myometrium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical resolution of diarrhoea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Frequency of CYP2D6 genetic polymorphisms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Frequency of CYP3A4/5 genetic polymorphisms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percent of successful DEA-NK cell infusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of adverse events for those who have a DEA-NK cell infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose of DEA-NK cell infusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial muscle protein fractional synthesis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abilhand-Kids
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pediatric Quality of Life Inventory (PedsQL) 3.0 Cerebral Palsy Module
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Ultrasound cumulative dispersed energy (CDE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of corneal endothelial cell density (ECD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pancreatic Allograft Viability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pancreatic Allograft Visibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pancreatic Allograft Uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of treatment switch
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients experiencing Dose limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of vital signs abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability: End of Intervention/Treatment Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility: End of Intervention/Treatment Questionnaire
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability: Client Satisfaction Questionnaire (CSQ-8-R)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Occurrence of healthcare events
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time of completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: User Experience survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient Experience survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: RT-PCR results for upper airway viral diagnostics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percent change in bone mineral density (BMD) of lumbar spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incident of overt and covert CNS injury 7 days post AF ablation
Endpoint domain: Adverse events/effects
Primary endpoint: Incident of overt and covert CNS injury 90 days post AF ablation
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of stone size reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HbA1c for glycemic control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ankle Brachial Index (ABI) for peripheral artery disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality of life for disease-specific patient reported outcomes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in cancer therapy functional assessment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change of functional connectivity of whole brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of hot flash severity
Endpoint domain: Adverse events/effects
Primary endpoint: Ventricular Tachycardia Inducibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Retention/attrition rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Appropriateness of clinical outcome measures
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Participants' perceived effectiveness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to achievement of Ct value ≥30
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: HBsAg reversion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Overall Response Rate (ORR) of gastrointestinal acute graft-versus-host disease (aGvHD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Duration for end-tidal oxygen level to rise to 85%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Duration for oxygen reserve index to rise to 0.55
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes from baseline in respiration rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes from baseline in heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Longer-term Pain
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Shorter-term Pain
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Global Response Assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of subjects achieving ACR50 Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Joint Attention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Expressive Language - Information
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Expressive Language - Grammar
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Expressive Vocabulary
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of quitline calls completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of varenicline pills taken
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cardiac output by thermodilution method
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: cardiac output by continuous carotid doppler blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Brachial flow-mediated dilation (FMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Carotid intima media thickness (CIMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of participants achieving neutrophil engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Pain score (VAS score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Between-day smallest real difference (SRD) for VO2 peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes